← Back

Abacus Global Management, Inc.

Abacus Global Management, Inc. operates as an alternative asset manager and market maker in the United States, Luxembourg, and internationally. The company operates in three segments: Asset Management, Life Solutions, and Technology Services segments. The Asset Management segment provides asset management services to investors investing in alternative investment and exchange-traded funds. The Life Solutions segment originates life insurance policy settlements between investors or buyers, and the sellers, who are often the original policy owners. The Technology Services segment provides real-time mortality verification, missing participant verification, and other services specific to the life insurance market services to customers on a contract basis. It sells its products through financial advisors or agents, direct-to-consumer, and traditional life settlements intermediaries. The company was formerly known as Abacus Life, Inc. and changed its name to Abacus Global Management, Inc. in February 2025. Abacus Global Management, Inc. was founded in 2004 and is headquartered in Orlando, Florida.

Price · split & dividend adjusted
News & notes moving ABX
ABX▲

Abacus Global Authorizes $100 Million Share Repurchase Program

Abacus Global Management has authorized a $100 million share repurchase program, commencing August 17. The board's decision aligns with the company's capital allocation framework. CEO Jay Jackson said the authorization reflects confidence in the company's vision, business model, and ability to generate attractive returns on capital. Abacus expects to fund the repurchase program through cash on hand.
ABX ▲
RTTNews·12dRead more ▾
Aging Population▲

Abacus Global Management Q2 2026 Earnings Beat Guidance

Abacus Global Management reported second quarter 2026 results that exceeded its own guidance, with total revenue of $73.0 million, up 30% year over year, and adjusted net income of $27.1 million, above the high end of its $24 million to $26 million forecast. Adjusted EPS was $0.28, up 22% from $0.23 a year earlier, and adjusted EBITDA rose 27% to $39.9 million. The company's Life Solutions segment drove growth with revenue of $65.4 million, a 38.3% increase, while longevity fund inflows reached $544.2 million in the first half, surpassing its $500 million target. Management provided third quarter guidance of $26 million to $28 million in adjusted net income and reiterated full-year adjusted net income of $100 million to $106 million. The company also announced the launch of its first registered interval fund, the ABX Longevity Growth and Income Fund, and a $53 million minority investment in Manning & Napier.
ABX ▲
Aging Population ▲Longevity & Life Extension ▲
The Motley Fool·13dRead more ▾
ABX▼

Court Unseals Key Evidence in Coventry Case, Revealing Abacus Global Management Relied on Low Lapetus Life Expectancy Estimates and Misled Investors

A U.S. District Court for the Middle District of Florida has unsealed documents in the litigation between Coventry First LLC and Abacus Global Management Inc., revealing that Abacus knowingly relied on unusually short life expectancy estimates from Lapetus Solutions and omitted critical facts from a public description of a valuation report it commissioned from Lewis & Ellis. The unsealed evidence shows that Lapetus reported a realized-to-expected mortality ratio of only 41.5%, meaning fewer than half of the predicted deaths occurred, while major life expectancy providers publicly disclose ratios near 100%. Internal communications indicate Abacus was aware of the disparity, including an email from CEO Jay Jackson questioning whether a policy valuation appeared too high because only Lapetus estimates were used, and a text from Lapetus’s former CEO stating he no longer trusted Abacus. The documents also show that Abacus issued a misleading press release about the Lewis & Ellis report, failing to disclose that it used a lower discount rate to inflate the valuation, provided internal life expectancy estimates for over a third of policies instead of independent ones, and withheld newer, longer life expectancy estimates for several large policies. Coventry, which refiled its answer and counterclaims with the newly unsealed evidence, alleges that Abacus misled investors and the public about its reliance on Lapetus estimates, which were used to originate, sell, and value life insurance policies held in its portfolio and sold to affiliated managed funds, including funds in which credit unions invested over $500 million.
ABX ▼
GlobeNewswire·21dRead more ▾
ABX▲

Abacus Global Management Upsizes Credit Facility by $75 Million to $225 Million

Abacus Global Management stock edged higher Monday after the company announced it had increased its existing syndicated credit facility by $75 million, bringing the total to $225 million. The additional lender commitments were secured through Glas USA, and the terms of the arrangement remain unchanged. The company also disclosed that board member Sean McNealy resigned effective June 30 as part of his planned retirement, and he will stay on in an advisory role. Abacus, which buys and bundles individual life insurance policies for investment, saw its shares close more than 1% higher, outperforming the S&P 500's 0.7% gain.
ABX ▲
The Motley Fool·51dRead more ▾
ABX▲

Goldman Sachs Outperforms Finance Sector with 16.2% Year-to-Date Gain

Goldman Sachs has returned 16.2% year-to-date, outperforming the broader Finance sector's average gain of 5.3%. The stock holds a Zacks Rank #2 (Buy), with its full-year earnings consensus estimate rising 4% over the past quarter. Within the Financial - Investment Bank industry, which has gained 7.6% this year, Goldman Sachs is also ahead. Another Finance stock, Abacus Global Management, has returned 38.7% year-to-date, while its industry, Financial - Miscellaneous Services, has declined 8.2%.
GS ▲ABX ▲
Zacks Investment Research·51dRead more ▾
© 2026 MarketDXAsset